Steve credo should buy spectra7 now while its cheap, credos cash position would help accelerate sales & allow for more patients. even with a premium price it would be less than 5 times 2022 sales. Credo is within few miles of spectra7 so this would be easy company to bring in the fold then credo could truly say they are tech leader